VTGN

VTGN

USD

Vistagen Therapeutics Inc. Common Stock

$2.360-0.040 (-1.667%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$2.400

高値

$2.498

安値

$2.350

出来高

0.11M

企業ファンダメンタルズ

時価総額

68.1M

業種

バイオテクノロジー

United States

取引統計

平均出来高

0.13M

取引所

NCM

通貨

USD

52週レンジ

安値 $1.9現在値 $2.360高値 $4.21

関連ニュース

BusinessWire

Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called

もっと見る
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
BusinessWire

Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year

Company's PALISADE-4 Phase 3 trial now expected to read out in the first half of 2026 Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry

もっと見る
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
BusinessWire

Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference

Posters Highlight New Insights into Social Anxiety Disorder and the Novel Mechanism of Action of Itruvone to Treat Major Depressive Disorder Vistagen (NASDAQ:VTGN), a clinical-stage biopharmaceutical company pioneering

もっと見る
Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference